Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1CNS 1

Conditions

Neuroblastoma 49Central Nervous System Neoplasms 46Medulloblastoma 26Brain Neoplasms 23Astrocytoma 23Sarcoma 15Testicular Neoplasms 14Oligodendroglioma 13Familial ependymoma 13Ovarian Neoplasms 12Glioblastoma 12Testicular Germ Cell Tumor 11Lymphoma 11Neuroectodermal Tumors, Primitive, Peripheral 10Wilms Tumor 9Optic Nerve Glioma 9Gliosarcoma 9Ependymoma 9Choroid Plexus Neoplasms 9Rhabdoid Tumor 8Retinoblastoma 8Glioma 8Teratoma 7Kidney Neoplasms 7Osteosarcoma 6Head and Neck Neoplasms 6Burkitt Lymphoma 6Recurrence 5Neuroectodermal Tumors, Primitive 5Esthesioneuroblastoma, Olfactory 5

Interventions

Dexamethasone 2Zidovudine 1Vincristine 1Methotrexate 1Leucovorin 1Filgrastim 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Filgrastim × CNS × Clear all
NCT00000801 2012-11-01

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
33 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡